down arrow

Fuso Pharmaceutical Industries Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3823600006
  • TKS: 4538
JPY
2,241.00
-24 (-1.06%)

Sep 24

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Elan Corp.
Katakura Industries Co., Ltd.
Daito Pharmaceutical Co., Ltd.
CellSource Co., Ltd.
Koa Shoji Holdings Co., Ltd.
Fuji Pharma Co., Ltd.
Seikagaku Corp.
Fuso Pharmaceutical Industries Ltd.
ASKA Pharmaceutical Holdings Co., Ltd.
SanBio Co., Ltd.
Noile-Immune Biotech, Inc.

Why is Fuso Pharmaceutical Industries Ltd. ?

1
Poor Management Efficiency with a low ROCE of 5.92%
  • The company has been able to generate a Return on Capital Employed (avg) of 5.92% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 14.69
  • Poor long term growth as Net Sales has grown by an annual rate of 4.93% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 14.69
  • The company has been able to generate a Return on Equity (avg) of 6.65% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.93% over the last 5 years
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fuso Pharmaceutical Industries Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Fuso Pharmaceutical Industries Ltd.
2.8%
-0.12
19.37%
Japan Nikkei 225
43.58%
1.48
29.43%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
4.93%
EBIT Growth (5y)
3.83%
EBIT to Interest (avg)
13.90
Debt to EBITDA (avg)
2.18
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
1.05
Tax Ratio
17.47%
Dividend Payout Ratio
38.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.63%
ROE (avg)
6.65%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.56
EV to EBIT
14.73
EV to EBITDA
8.61
EV to Capital Employed
0.73
EV to Sales
0.68
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
4.98%
ROE (Latest)
13.50%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
RAW MATERIAL COST(Y)

Fallen by 0.59% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 2.51 times

-18What is not working for the Company
NET PROFIT(HY)

At JPY 908.12 MM has Grown at -73.75%

INTEREST(HY)

At JPY 206 MM has Grown at 71.67%

CASH AND EQV(HY)

Lowest at JPY 9,420 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.05 times

Here's what is working for Fuso Pharmaceutical Industries Ltd.

Debtors Turnover Ratio
Highest at 2.51 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by 0.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
At JPY 653 MM has Grown at 29.31%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (JPY MM)

Here's what is not working for Fuso Pharmaceutical Industries Ltd.

Net Profit
At JPY 908.12 MM has Grown at -73.75%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Interest
At JPY 206 MM has Grown at 71.67%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv
Lowest at JPY 9,420 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio
Lowest at 3.05 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Footer loading